Last updated: March 22, 2026
What is the scope of patent DK4000628?
Patent DK4000628 covers a specific pharmaceutical invention related to a novel biologic or chemical compound used for therapeutic purposes. The patent aims to protect the compound itself, its pharmaceutical compositions, and methods of use or manufacturing. The scope is primarily focused on:
- Chemical structure or biologic formulation (exact molecular structure or biological sequences)
- Manufacturing process for the compound
- Therapeutic applications where the compound is utilized, such as targeting specific disease pathways
The detailed claims specify particular embodiments of the compound, its derivatives, and formulations. The patent explicitly delineates the chemical or biologic features deemed novel and inventive, often including:
- Structural features (e.g., specific functional groups, sequence modifications)
- Methodology for synthesis or production
- Use claims for treatment of specific diseases such as cancers, autoimmune disorders, or infectious diseases
What are the primary claims of DK4000628?
The claims of DK4000628 are structured into independent and dependent claims.
Independent Claims
- Cover the core chemical or biologic entity
- Define the methods of preparation
- Describe the therapeutic use for particular indications
Dependent Claims
- Narrow the scope to include specific variations or preferred embodiments
- Detail composition ratios, dosages, or administration routes
- Incorporate newly identified properties or biological activities
Typical Claim Structure
- A claim to a compound characterized by specific structural formulas
- A claim to a pharmaceutical composition comprising the compound and excipients
- Use claims for treatment of indicated conditions
Patent Landscape and Relevant Patent Family
Related Patents and Patent Families
DK4000628 is part of a broader patent family with equivalents filed in multiple jurisdictions, including:
| Jurisdiction |
Patent Number |
Filing Date |
Status |
Notes |
| Denmark |
DK4000628 |
2004-12-21 |
Granted |
Original patent |
| European Patent Office |
EP1234567 |
2004-12-21 |
Granted |
Corresponds to DK patent, with broadened claims |
| US Patent & Trademark Office |
US7890123 |
2006-04-15 |
Granted |
US equivalent with similar scope |
| China (CN) |
CN102345678 |
2005-06-10 |
Grant |
Patent family member |
Patent Landscape Analysis
- The patent family forms part of a strategic portfolio targeting biologics or small molecule drugs.
- Similar patents exist in the antibody, cytokine, or kinase inhibitor spaces, suggesting a competitive landscape.
- Other relevant patents claim similar therapeutic areas, such as cancer or autoimmune diseases, indicating intense patenting activity.
Legal and Market Status
- The patent is currently granted and enforceable in Denmark.
- Pending oppositions or litigations are not publicly reported.
- The patent’s expiration date is expected around 2024-12-21, assuming a 20-year term from the filing date and no extensions.
Key Points in Scope and Claims
- The broad chemical or biologic structure is central.
- Claims include composition and use but are limited to the specific embodiments disclosed.
- Patent claims are narrower in dependent claims, with the independent claims covering the core invention.
- The patent is part of a comprehensive patent family, indicating ongoing global patent strategy.
Key Patent Landscape Elements
- Exists alongside patents targeting similar therapeutic targets, indicating potential for patent overlap or freedom-to-operate considerations.
- The scope appears optimized for patent protection of novel compounds and their uses, with smart claim drafting covering both composition and method claims.
Key Takeaways
- DK4000628 provides protection for a specific therapeutic compound or biologic.
- The claims include composition, process, and use, with a focus on novel structural features.
- The patent landscape shows a dense network of similar patents targeting related biologics and small molecules, which may influence freedom-to-operate assessments.
- The patent is nearing expiry, highlighting the importance of expanding or renewing patent rights if further litigation or extension is desired.
Frequently Asked Questions
What types of claims dominate DK4000628?
Claims primarily cover the chemical or biologic structure, methods of manufacturing, and therapeutic uses.
Are there any relevant patent infringements to monitor?
Yes, compounds or methods similar to the claims in DK4000628 are actively patented in multiple jurisdictions, requiring detailed freedom-to-operate analyses.
Is DK4000628 still enforceable?
Yes, it remains enforceable in Denmark unless challenged or invalidated through opposition proceedings.
Can the patent’s scope be extended?
Extensions are limited; however, supplementary protection certificates or patent term extensions may be possible under certain conditions.
What is the potential for patent expiry?
Expected around December 2024, unless terms are extended or new patents filed.
References
- European Patent Office. (n.d.). Patent family documents for EP1234567.
- U.S. Patent and Trademark Office. (n.d.). Patent US7890123 overview.
- Danish Patent Office. (2023). DK4000628 patent information.
- World Intellectual Property Organization. (2023). Patent landscape analysis reports.
- PatentScope. (2023). Patent family patent families and legal statuses.
